Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
drugs
4
×
national blog main
new york
4
×
boston blog main
clinical trials
life sciences
national top stories
new york blog main
new york top stories
biotech
boston top stories
medical devices
san diego blog main
san diego top stories
texas
texas blog main
texas top stories
akcea therapeutics
alirocumab
alnylam pharmaceuticals
amgen
ancor capital partners
antibiotics
anylam pharmaceuticals
arvinas
astrazeneca
australia
biobridge
boston
boulder/denver
boulder/denver blog main
boulder/denver top stories
cancer
carbapenem-resistant enterobacteriaceae
cardiomyopathy
celgene
darlene boudreaux
detroit
detroit blog main
detroit top stories
What
alnylam
drug
medical
medicines
new
ago
akcea
amyloidosis
announced
approved
attr
available
based
battle
biobridge
biotechs
catch
center
cholesterol
chose
close
company
data
debilitating
device
disease
evidence
execs
expansion
fannin
fda
firms
genetic
heart
innovation
ipo
ipos
lasting
latest
let’s
Language
Current search:
photo
×
" new york "
×
drugs
×
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
TX Roundup: TMC’s BioBridge to the UK, New Execs at Fannin & TechFW
